Creative Medical Technology Holdings Inc (CELZ)

[monte379]

And what is so cool is that our favorite ticker, CELZ, is working on StemSpine another regenerative stem cell treatment. From a medical point of view, I can barely wait until it’s available. And from an investment standpoint, well, it’s another revenue stream coming sooner than later.

StemSpineTM is expected to launch in late 2019. We feel it is in the best interest of the company to dedicate much of our resources to continue to build those brands and our cash flow before commercializing StemSpine.